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oi:10.1016/j.fThe vitamin E–binding protein afamin is
altered significantly in the peritoneal
fluid of women with endometriosisThe objective of this case-control study of 242 reproductive-age women was to determine the concentration of
afamin in the serum and peritoneal fluid of womenwith andwithout endometriosis and to test afamin as a diagnostic
marker of endometriosis. Afamin levels were altered significantly in the peritoneal fluid of women with endome-
triosis compared with disease-free controls, correlated with vitamin E levels, and are consistent with increased
oxidative stress in the peritoneal cavity of women with endometriosis. (Fertil Steril 2010;94:2923–6. 2010
by American Society for Reproductive Medicine.)
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PubliOxidative stress has been implicated as a component of the inflam-
matory reaction seen in endometriosis. Retrograde menstruation
may carry pro-oxidant factors, including heme and iron, into the
peritoneal cavity (2). Consequently, peritoneal fluid (PF) of
women with endometriosis contains increased levels of markers
of lipid peroxidation and of enzymes involved in the generation
of reactive oxidant species (3, 4).
Vitamin E belongs to the family of nonenzymatic antioxidants
and has been shown to be bound to afamin, its specific carrier
protein in extravascular fluids (5). Subsequently, afamin was
demonstrated to be present abundantly in follicular fluid, where
its concentration correlated significantly with vitamin E levels,
suggesting a possible role in oocyte development (6).
Murphy et al. (3) showed that vitamin E levels were signifi-
cantly lower in the PF of women with endometriosis, attributing
this finding to a local decrease of antioxidants caused by excessive
oxidative stress. In a recent publication, Lambrinoudaki et al. (7)
demonstrated that several markers of oxidative stress are elevated
in the serum of women with endometriosis, suggesting a systemic
phenomenon. Recently, we found a nonsignificant trend to lower
serum afamin levels in women with benign gynecologic inflamma-
tory conditions, including endometriosis, compared with healthy
controls (8, 9).
The objectives of this study were [1] to determine whether
afamin levels correlate with vitamin E levels in pelvic PF; [2] to
test the hypothesis that concentrations of afamin in the PF, and
perhaps also in serum, are lower in women with endometriosis
compared with those without endometriosis; and [3] to test the
potential use of afamin as a diagnostic marker of endometriosis,
comparing it with CA-125, the most widely accepted marker of
endometriosis.
This study was approved by the Institutional Review Boards of
the University of Pennsylvania and the Medical University of
Innsbruck, and written informed consent was obtained. We
included women 18 to 48 years of age undergoing surgery for
infertility, pelvic pain, tubal sterilization or reversal, or other
benign indication. We excluded women with knownFertility and Sterility Vol. 94, No. 7, December 2010 2923
pyright ª2010 American Society for Reproductive Medicine,
shed by Elsevier Inc. Open access under CC BY-NC-ND license. 
FIGURE 1
(A) Absolute PF afamin levels by stage of endometriosis and in
the control group, by presence of symptoms. *Difference
(P< .05) between stage I, II, III, and Control: Healthy. ^Difference
(P< .05) between stage II and Control: Pain/Infert. (B) Afamin as
a percentage of total PF protein (afamin/total protein) by
endometriosis stage and control groups *Difference (P< .01)
between stage I, stage II, and Control: Healthy.
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2rheumatologic diseases or acute or chronic infections (including
HIV) and those taking long-term anti-inflammatory medications.
We did not exclude the relatively few women who were taking
antidepressants (N ¼ 12), antihypertensives (N ¼ 11), antihista-
mines (N ¼ 15), thyroid medications (N ¼ 10), or inhaled bron-
chodilators (N ¼ 4). These were distributed approximately evenly
among groups.
Blood and PF were collected in the perioperative period, and
endometriosis was recorded and staged according to the American
Society for Reproductive Medicine scoring system (10). The
timing of surgery was as follows: 63% and 58% follicular phase,
22% and 26% luteal phase, and the remaining unknown, for the
endometriosis and control groups, respectively.
Concentrations of afamin were quantified in serum and PF in
duplicate by sandwich-type ELISA, as previously described
(5, 6). CA-125 was measured in duplicate in serum and PF with
use of ELISA kits (Panomics, Inc., Redwood City, CA, and
Abbott, Inc., Vienna, Austria). Vitamin E was measured by high-
performance liquid chromatography–ultraviolet (Chromsystems,
Munich, Germany). Total protein content was measured in PF
with use of a micro-bicinchoninic protein assay (BCA; Pierce,
Inc., Rockford, IL).
Baseline characteristics of the two groups were compared with
use of t-test, c2, and Fisher’s exact test, where appropriate. Mean
concentrations of afamin and CA-125 were compared between
groups with use of nonparametric tests: the Kruskal-Wallis and
Mann-Whitney tests. Bivariate relations were analyzed with the
Spearman correlation coefficient and multivariate relations with
a stepwise linear regression based on Akaike’s information crite-
rion. Multivariate analyses were performed to predict the presence
of endometriosis and of infertility, accounting for missing values.
The independent variables used were age, endometriosis, pelvic
pain, infertility, serum afamin, serum CA-125, and PF afamin/PF
protein. Sensitivity and specificity for afamin and CA-125 (log
transformed) were assessed with receiver operating characteristic
curves (11). Statistical analyses were performed with use of the
laboratory results of serum analyzed from all 242 study subjects
and the results of PF that had been procured from 160 of the study
subjects (stage I¼ 49, stage II¼ 22, stage III¼ 14, stage IV¼ 21,
controls ¼ 54).
Of the 143 women in the endometriosis group, 66 (46%) had
stage I, 22 (15%) stage II, 21 (15%) stage III, and 34 (24%)
stage IV disease. The primary indication for surgery was pain
in 93 (65%) and 23 (23%) and infertility in 42 (29%) and 37
(37%) in the endometriosis and control groups, respectively.
The control group comprised 99 women without endometriosis.
Sixty-nine of these had symptoms and had the following opera-
tive diagnoses: 11 myoma, 11 adhesive disease, 8 hydrosalpinx,
5 ovarian cyst, 2 paratubal cyst, 1 corpus luteum, 1 other
(M€ullerian anomaly), 29 no visible pelvic pathology. Thirty
women in the control group were symptom free and underwent
tubal ligation–reanastomosis surgery. In certain analyses, there-
fore, we further separated the control group into a symptomatic
(infertility or pain, N ¼ 69) and a symptom-free ‘‘healthy’’
subgroup (N ¼ 30).
We found that PF afamin concentration correlated signifi-
cantly with the PF vitamin E concentration (r ¼ 0.635, 95%
confidence interval 0.504–0.737, P<.0001). There were no924 Seeber et al. Correspondencedifferences in PF vitamin E–protein concentrations between
women with and without endometriosis, regardless of stage of
disease.
Mean concentrations of serum afamin were similar between the
endometriosis and control groups, 63.36  1.50 mg/mL and 63.86
 1.61 mg/mL, respectively. There were no differences in serum
afamin concentrations between groups when separated by stage
of endometriosis.Vol. 94, No. 7, December 2010
FPeritoneal fluid afamin levels, however, were significantly
different between the two groups (25.87  1.41 mg/mL and
31.91  1.88 mg/mL, P¼.012). The mean concentrations of PF
afamin were different, with stage III endometriosis having the
lowest PF afamin (20.68  4.63 mg/mL) and the asymptomatic
controls the highest (37.45  2.89 mg/mL) (Fig. 1A).
To control for potential cycle-dependent PF volume differences
and for a potential dilution effect in the 10 cases of hysteroscopic
irrigation with normal saline solution before laparoscopy, we
determined the protein content of the PF samples and then calcu-
lated the ratio of afamin to total protein, which we report as
a percentage of afamin of PF protein. This relative afamin value
is the one we used for further analyses.
Interestingly, we found substantial differences in the total PF
protein content between groups, suggesting that the PF is more di-
luted in subjectswith endometriosis. Thus, although the afamin/total
protein in the PF remained significantly different between groups,
the levels were nearly converse to those we observed when we
only measured the absolute concentration of PF afamin (Fig. 1B).
With use of receiver operating characteristic curves, the area
under the curve for afamin/total protein for the diagnosis of endo-
metriosis was 0.601 (95% confidence interval 0.506–0.697,
P¼.045). In comparison, the area under the curve for serum
CA-125 was 0.634 (95% confidence interval 0.563–0.705,
P¼.0005). There was no statistically significant difference in PF
CA-125 concentrations between groups. Neither serum nor PF
afamin levels correlated with their respective CA-125 levels
(Spearman r ¼ 0.01, P¼.87; Spearman r ¼ 0.01, P¼.82).
The Akaike’s information criterion optimal multivariable logis-
tic model for predicting endometriosis included as predictors
pelvic pain, serum afamin, serum CA-125, and PF afamin/PF total
protein, but serum afamin was statistically not significant (P¼.17).
The odds of endometriosis rose by 60% with a doubling of serum
CA-125 (odds ratio ¼ 1.60, P¼.0003) and were reduced by only
2% if serum afamin rose by one unit (odds ratio ¼ 0.98, P¼.17).
Patients with pelvic pain had a more than four times higher risk
of endometriosis than patients without pelvic pain (odds ratio ¼
4.18, P<.0001). The odds of endometriosis rose by 24% if PF
afamin/PF total protein rose by 1% (unit) (odds ratio ¼ 1.24,
P¼.028).
The stepwise logistic regression method for predicting infertil-
ity did not find any predictors; neither CA-125, serum afamin,
endometriosis, nor any of the other covariates were found to
reliably predict infertility. On multivariate analysis, PF afamin/ertility and SterilityPF protein was not predictive of infertility among the subset of
subjects with endometriosis.
In conclusion, we were able to demonstrate for the first time that
afamin concentration is strongly correlated with vitamin E concen-
tration also in PF, a correlation that we previously demonstrated in
other extravascular fluids such as follicular fluid and cerebrospinal
fluid (6). We found that afamin makes up a higher percentage of
the protein content of PF in subjects with endometriosis. This
difference was especially pronounced when comparing those
with stage I and II disease with healthy, asymptomatic control sub-
jects. Subjects with stage III and IV disease and endometriosis-free
subjects with pelvic pain and/or infertility (symptomatic control
subgroup) appeared to have intermediate (though not statistically
significant) PF afamin concentrations.
The calculation of greater amounts of afamin in lower-stage
endometriosis appears contradictory to the single publication on
this subject (3), which might be due to the very small study size
of that work. We hypothesize that the higher afamin PF content
of the PF protein in stage I and II endometriosis may be a reflection
of a more acute stage of disease and signify an active recruitment
of antioxidants, including vitamin E, to this local inflammatory en-
vironment. Conversely, the chronic state of higher-stage endome-
triosis is associated with less active inflammation and thus lower
concentrations of antioxidants. It follows that healthy control
subjects have the lowest levels of the antioxidant in the PF. These
findings confirm previous reports of endometriosis causing local-
ized inflammation and oxidative stress in the peritoneal cavity,
albeit this inflammation may be disease stage specific (5, 12, 13).
On logistic regression analysis, CA-125 and the clinical pres-
ence of pelvic pain were both better predictors of endometriosis
than either serum afamin or PF afamin/PF protein. To our surprise,
none of the variables that we evaluated were predictive of
infertility.
In summary, we found differences in PF afamin levels between
women with and without endometriosis, a finding that confirms the
link between the disease and localized oxidative stress. Future
studies further evaluating the association between markers of
oxidative stress and endometriosis-associated infertility and ones
investigating the potential therapeutic benefits of antioxidants
are warranted.
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